glp-1 and macular degeneration Drugs Linked to Small but Worrying Increase in Wet AMD Risk GLP-1 Drugs Could Double Risk

Mansour, I

Aberrant immune responses promote vascular inflammation, leading to endothelial dysfunction, vascular remodeling, and increased peripheral vascular resistance, which eventually drive blood pressure elevation (235, 236)

The AngioSafe 1 study, which is also designed to clarify the association between exposure to GLP-1R agonists and diabetic retinopathy through clinical and preclinical study designs found no risk for severe diabetic retinopathy when patients were treated with GLP-1R agonists, and no effect of GLP-1R agonists on angiogenesis (Gaborit et al., 2020)

A comprehensive pre-treatment panel typically includes a Complete Metabolic Panel (CMP) to assess liver and kidney function, a Complete Blood Count (CBC), thyroid function tests (TSH, Free T3, Free T4), fasting glucose and insulin levels, HbA1c, and a lipid panel

At Rewind Anti-Aging of Miami, treatment plans are designed around your specific lab results, symptoms, health history, and goals